Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.30 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12879484 | 0.97 | CYP1A2 (0.36) | CYP1A2CNR1CNR2 | |
| SCHEMBL846790 | 0.85 | CYP1A2 (0.39) | CYP1A2CNR1CNR2 | |
| SCHEMBL17565668 | 0.83 | CYP1A2 (0.43) | CYP1A2CNR1CNR2 | |
| SCHEMBL15628148 | 0.81 | — | — | |
| SCHEMBL15791376 | 0.81 | — | — | |
| SCHEMBL6720163 | 0.78 | — | — | |
| SCHEMBL9251554 | 0.78 | — | — | |
| SCHEMBL19600553 | 0.77 | SIGMAR1 (0.33) | — | |
| SCHEMBL14213781 | 0.76 | SHBG (0.35) | CYP1A2 | |
| SCHEMBL15864532 | 0.76 | CYP1A2 (0.33) | CYP1A2CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542550-B2 | Labeled nucleotides | ILLUMINA, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-20200157618-A1 | LABELED NUCLEOTIDES | ILLUMINA, INC. | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200157618-A1 | LABELED NUCLEOTIDES | GJB2, KCNN4, NME4 | CYP1A2 3875/4885CNR1 4115/4885CNR2 4033/4885 |
| US-11542550-B2 | Labeled nucleotides | GJB2, KCNN4, NME4 | CYP1A2 3875/4885CNR1 4115/4885CNR2 4033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.